Investor Relations


SciClone Pharmaceuticals (NASDAQ: SCLN) is a revenue-generating, China-centric, specialty pharmaceutical company with a substantial international business and a product portfolio of novel therapies for cancer and infectious diseases. The Company is focused on continuing sales growth and

... More »

pdf SciClone Corporate Presentation February, 2015.

Recent Releases

Feb 25, 2015
SciClone Pharmaceuticals to Report Financial Results for the Fourth Quarter and Full Year 2014 on March 11th

Jan 28, 2015
SciClone to Present at BIO CEO & Investor Conference on February 9, 2015 at 11 am ET

View all releases »

Events & Presentations

Mar 11, 2015 at 4:30 PM ET
Q4 2014 SciClone Pharmaceuticals, Inc. Earnings

Feb 9, 2015 at 11:00 AM ET
BIO CEO & Investor Conference

View all events & presentations »

Stock Chart
Stock price graph
3 Mo.   6 Mo.   1 Yr.
Stock Quote
SciClone Pharmaceuticals, Inc.
Price: 7.84
Change: + 0.05
Day High: 7.87
Day Low: 7.76
Volume: 25,000
Delayed at least 20 minutes.
Provided by eSignal.